Déclaration de participation

Kuros Biosciences AG

Taux déclaré collectivement

17.07%

Seuil

Franchi à la hausse

Chronologie

Publication

16.05.2015

Transaction

11.05.2015

Répartition des droits

Droits de vote acquis17.07%
Droits de vote cédés0%
Sous le seuil0%

Ayants droit économique déclarés · 2

Une seule déclaration, déposée collectivement : le taux de droits de vote porte sur le groupe entier, pas sur chaque personne.

Détails de l'annonce

CatégorieGroupe d'actionnaires
Place de cotationXSWX

Identifiant de déclaration

TBF5C00035

Ayant droit économique

Abingworth LLP

Adresse déclarée

Abingworth LLP, SW1Y 6DN, London

Acquisition and restructuring of convertible bonds followed by a sale of shares. The restructuring of the convertible bonds announced by the Company has been effected. The percentage indicated below is based on the increased share capital of the Company (as per entry in the commercial register). - Shares and warrants are directly held by Abingworth Bioventures V L.P., 38 Jermyn Street, London SW1Y 6DN, which is controlled by Abingworth Bioventures V GP L.P., 50 Lothian Road, Festival Square, Edinburgh, EH3 9WJ, as general partner. Abingworth Bioventures V GP L.P, in turn, is controlled by Abingworth General Partner V LLP, 38 Jermyn Street, London SW1Y 6DN, as general partner. Abingworth General Partner V LLP, in turn, is controlled by Abingworth Bioventures V GP Limited, 50 Lothian Road, Festival Square, Edinburgh, EH3 9WJ. Abingworth Bioventures V GP Limited, in turn, is controlled by Abingworth LLP, 38 Jermyn Street, London SW1Y 6DN. Certain employee options on shares in the Company are held for the account of Abingworth LLP as the investment manager of Abingworth Bioventures V L.P., by Joseph Anderson, Surrey, UK. - Warrants are directly held by Abingworth Bioequities Master Fund Limited, PO Box 309, Ugland House, Grand Cayman KY1-1104, Cayman Island, which operates as an integrated investment structure. Abingworth Bioequities Master Fund Limited is fed by (i) Abingworth Bioequities Fund Limited, PO Box 309, Ugland House, Grand Cayman KY1-1104, Cayman Islands, and by (ii) Abingworth Bioequities Fund L.P., 1209 Orange Street, City of Wilmington, County of New Castle, Delaware 19801, USA. Abingworth Bioequities Fund Limited is managed by Abingworth LLP, 38 Jermyn Street, London SW1Y 6DN, UK. Abingworth Bioequities Fund L.P is controlled by Abingworth Bioequities GP Limited, PO Box 309, Ugland House, Grand Cayman KY1-1104, Cayman Islands, as general partner. Abingworth Bioequities GP Limited, in turn, is controlled by Abingworth LLP, 38 Jermyn Street, London SW1Y 6DN, UK.

Ces chiffres sont des agrégats de déclarations publiques. Ils ne constituent pas un conseil en investissement.

Source: SIX Exchange Regulation

insider24.ch

Ne manquez plus aucun signal de marché

Alertes ProPar e-mail et Telegram après publication
Suivi de sociétés illimitéListe de suivi illimitée avec le plan Pro
Récapitulatif du lundiL'essentiel de vos valeurs à l'ouverture